Cheryl Cohen to Cost-Benefit Analysis
This is a "connection" page, showing publications Cheryl Cohen has written about Cost-Benefit Analysis.
Connection Strength
0,971
-
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme. Vaccine. 2021 01 08; 39(2):412-422.
Score: 0,160
-
Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
Score: 0,158
-
Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
Score: 0,154
-
Quantifying How Different Clinical Presentations, Levels of Severity, and Healthcare Attendance Shape the Burden of Influenza-associated Illness: A Modeling Study From South Africa. Clin Infect Dis. 2019 08 30; 69(6):1036-1048.
Score: 0,146
-
Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
Score: 0,139
-
The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018 02 08; 36(7):997-1007.
Score: 0,131
-
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. BMC Med. 2023 03 31; 21(1):120.
Score: 0,047
-
A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa. Vaccine. 2019 10 31; 37(46):6874-6884.
Score: 0,037